Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

CFH and ARMS2 Polymorphisms Interact with Zinc Supplements in Cognitive Impairment in the Women's Health Initiative Hormone Trial.

Kustra R, Awh CC, Rojas-Fernandez C, Zanke B.

J Alzheimers Dis. 2018 Oct 5. doi: 10.3233/JAD-180673. [Epub ahead of print]

PMID:
30320589
2.

Deprescribing recommendations: An essential consideration for clinical guideline developers.

Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B.

Res Social Adm Pharm. 2018 Sep 18. pii: S1551-7411(18)30777-0. doi: 10.1016/j.sapharm.2018.08.014. [Epub ahead of print]

PMID:
30241877
3.

Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes.

Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A.

Can Fam Physician. 2018 Jan;64(1):e1-e12. Review. French.

PMID:
29358261
Free PMC Article
4.

Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.

Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A.

Can Fam Physician. 2018 Jan;64(1):17-27. Review.

5.

Déprescription des antihyperglycémiants chez les personnes âgées: Guide de pratique clinique fondé sur les données probantes.

Farrell B, Black C, Thompson W, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Bouchard M, Welch V.

Can Fam Physician. 2017 Nov;63(11):e452-e465. French.

PMID:
29138168
Free PMC Article
6.

Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.

Farrell B, Black C, Thompson W, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Bouchard M, Welch V.

Can Fam Physician. 2017 Nov;63(11):832-843.

7.

Assessment of Oral Anticoagulant Use in Residents of Long-Term Care Homes: Evidence for Contemporary Suboptimal Use.

Rojas-Fernandez CH, Goh J, Hartwick J, Auber R, Zarrin A, Warkentin M, Hudani Z.

Ann Pharmacother. 2017 Dec;51(12):1053-1062. doi: 10.1177/1060028017723348. Epub 2017 Jul 26.

PMID:
28745065
8.

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P.

Can Fam Physician. 2017 May;63(5):354-364.

9.

Deprescribing versus continuation of chronic proton pump inhibitor use in adults.

Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, Pottie K, Farrell B.

Cochrane Database Syst Rev. 2017 Mar 16;3:CD011969. doi: 10.1002/14651858.CD011969.pub2. Review.

PMID:
28301676
10.

The ACHRU-CPP versus usual care for older adults with type-2 diabetes and multiple chronic conditions and their family caregivers: study protocol for a randomized controlled trial.

Markle-Reid M, Ploeg J, Fraser KD, Fisher KA, Akhtar-Danesh N, Bartholomew A, Gafni A, Gruneir A, Hirst SP, Kaasalainen S, Stradiotto CK, Miklavcic J, Rojas-Fernandez C, Sadowski CA, Thabane L, Triscott JA, Upshur R.

Trials. 2017 Feb 6;18(1):55. doi: 10.1186/s13063-017-1795-9.

11.

Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review.

Black CD, Thompson W, Welch V, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Farrell B.

Diabetes Ther. 2017 Feb;8(1):23-31. doi: 10.1007/s13300-016-0220-9. Epub 2016 Dec 15. Review.

12.

The Aging, Community and Health Research Unit-Community Partnership Program for older adults with type 2 diabetes and multiple chronic conditions: a feasibility study.

Markle-Reid M, Ploeg J, Fisher K, Reimer H, Kaasalainen S, Gafni A, Gruneir A, Kirkconnell R, Marzouk S, Akhtar-Danesh N, Thabane L, Rojas-Fernandez C, Upshur R.

Pilot Feasibility Stud. 2016 May 9;2:24. eCollection 2016.

13.

Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration.

Rojas-Fernandez CH, Tyber K.

Ann Pharmacother. 2017 Mar;51(3):264-270. doi: 10.1177/1060028016680643. Epub 2016 Nov 19. Review.

PMID:
27866147
14.

A scoping review on medication adherence in older patients with cognitive impairment or dementia.

Hudani ZK, Rojas-Fernandez CH.

Res Social Adm Pharm. 2016 Nov - Dec;12(6):815-829. doi: 10.1016/j.sapharm.2015.11.011. Epub 2015 Dec 2. Review.

PMID:
26797263
15.

Atypical antipsychotics for insomnia: a systematic review.

Thompson W, Quay TAW, Rojas-Fernandez C, Farrell B, Bjerre LM.

Sleep Med. 2016 Jun;22:13-17. doi: 10.1016/j.sleep.2016.04.003. Epub 2016 May 11. Review.

PMID:
27544830
16.

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing.

Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V.

PLoS One. 2016 Aug 12;11(8):e0161248. doi: 10.1371/journal.pone.0161248. eCollection 2016.

17.

Improving the legibility of prescription medication labels for older adults and adults with visual impairment.

Leat SJ, Krishnamoorthy A, Carbonara A, Gold D, Rojas-Fernandez C.

Can Pharm J (Ott). 2016 May;149(3):174-84. doi: 10.1177/1715163516641432. Epub 2016 Apr 11.

18.

Statins and Cognitive Side Effects: What Cardiologists Need to Know.

Rojas-Fernandez C, Hudani Z, Bittner V.

Endocrinol Metab Clin North Am. 2016 Mar;45(1):101-16. doi: 10.1016/j.ecl.2015.09.007. Review.

PMID:
26893000
19.

Use of fall risk increasing drugs in residents of retirement villages: a pilot study of long term care and retirement home residents in Ontario, Canada.

Rojas-Fernandez C, Dadfar F, Wong A, Brown SG.

BMC Res Notes. 2015 Oct 14;8:568. doi: 10.1186/s13104-015-1557-2.

20.

Measuring the implementation of a group-based Lifestyle-integrated Functional Exercise (Mi-LiFE) intervention delivered in primary care for older adults aged 75 years or older: a pilot feasibility study protocol.

Gibbs JC, McArthur C, Milligan J, Clemson L, Lee L, Boscart VM, Heckman G, Rojas-Fernandez C, Stolee P, Giangregorio LM.

Pilot Feasibility Stud. 2015 May 31;1:20. eCollection 2015.

21.

Statins and cognitive side effects: what cardiologists need to know.

Rojas-Fernandez C, Hudani Z, Bittner V.

Cardiol Clin. 2015 May;33(2):245-56. doi: 10.1016/j.ccl.2015.02.008. Review.

PMID:
25939297
22.

Can 5-HT3 Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order.

Rojas-Fernandez CH.

Drugs Real World Outcomes. 2014 Dec;1(1):3-5. No abstract available.

23.

Use of ultra-low-dose (≤6 mg) doxepin for treatment of insomnia in older people.

Rojas-Fernandez CH, Chen Y.

Can Pharm J (Ott). 2014 Sep;147(5):281-9. doi: 10.1177/1715163514543856. Review.

24.

Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.

Rojas-Fernandez C, Stephenson AL, Fischer HD, Wang X, Mestre T, Hutson JR, Pondal M, Lee DS, Rochon PA, Marras C.

Drugs Aging. 2014 Nov;31(11):805-13. doi: 10.1007/s40266-014-0215-z.

PMID:
25227452
25.

The legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labels.

Leat SJ, Ahrens K, Krishnamoorthy A, Gold D, Rojas-Fernandez CH.

Can Pharm J (Ott). 2014 May;147(3):179-87. doi: 10.1177/1715163514530094.

26.

Helping pharmacists to reduce fall risk in long-term care: A clinical tool to facilitate the medication review process.

Rojas-Fernandez CH, Seymour N, Brown SG.

Can Pharm J (Ott). 2014 May;147(3):171-8. doi: 10.1177/1715163514529706.

27.

An assessment by the Statin Cognitive Safety Task Force: 2014 update.

Rojas-Fernandez CH, Goldstein LB, Levey AI, Taylor BA, Bittner V, The National Lipid Association's Safety Task Force.

J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S5-16. doi: 10.1016/j.jacl.2014.02.013.

PMID:
24793442
28.

An interdisciplinary memory clinic: a novel practice setting for pharmacists in primary care.

Rojas-Fernandez CH, Patel T, Lee L.

Ann Pharmacother. 2014 Jun;48(6):785-95. doi: 10.1177/1060028014526857. Epub 2014 Mar 20.

PMID:
24651163
29.

Psychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice.

Rojas-Fernandez C, Mikhail M, Brown SG.

Ann Pharmacother. 2014 Apr;48(4):438-46. doi: 10.1177/1060028013520196. Epub 2014 Jan 28.

PMID:
24473493
30.

Contemporary concepts in the pharmacotherapy of depression in older people.

Rojas-Fernandez C, Mikhail M.

Can Pharm J (Ott). 2012 May;145(3):128-135.e2. doi: 10.3821/145.3.cpj128.

31.

Little evidence that cholinesterase inhibitors prevent progression of mild cognitive impairment to dementia, but they are associated with adverse effects.

Rojas-Fernandez CH.

Evid Based Ment Health. 2013 May;16(2):39. doi: 10.1136/eb-2012-101087. Epub 2013 Jan 7. No abstract available.

PMID:
23299054
32.

Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health?

Rojas-Fernandez CH, Maclaughlin EJ, Dore NL, Ebsary S.

Ann Pharmacother. 2012 May;46(5):696-702. doi: 10.1345/aph.1Q627. Epub 2012 May 8. Review.

PMID:
22570431
33.

Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.

Rojas-Fernandez CH, Cameron JC.

Ann Pharmacother. 2012 Apr;46(4):549-57. doi: 10.1345/aph.1Q620. Epub 2012 Apr 3. Review.

PMID:
22474137
34.

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

Robb AS, Andersson C, Bellocchio EE, Manos G, Rojas-Fernandez C, Mathew S, Marcus R, Owen R, Mankoski R.

Prim Care Companion CNS Disord. 2011;13(1). pii: PCC.10m01008. doi: 10.4088/PCC.10m01008gry.

35.

Considerations in the treatment of geriatric depression: Overview of pharmacotherapeutic and psychotherapeutic treatment interventions.

Rojas-Fernandez CH, Miller LJ, Sadowski CA.

Res Gerontol Nurs. 2010 Jul;3(3):176-86. doi: 10.3928/19404921-20100526-01. Epub 2010 Jun 30. Review. Erratum in: Res Gerontol Nurs. 2010 Oct;3(4):239. Dosage error in article text.

PMID:
20635802
36.

Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.

Rojas-Fernandez CH, Moorhouse P.

Ann Pharmacother. 2009 Jul;43(7):1310-23. doi: 10.1345/aph.1L703. Epub 2009 Jul 7. Review.

PMID:
19584390
37.
38.

Inappropriate medications and older people: has anything changed over time?

Rojas-Fernandez CH.

Ann Pharmacother. 2003 Jul-Aug;37(7-8):1142-4. No abstract available.

PMID:
12841831
41.

Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease.

Rojas-Fernandez CH, Chen M, Fernandez HL.

Pharmacotherapy. 2002 Dec;22(12):1547-63. Review.

PMID:
12495166
42.

Underutilization of aspirin for secondary prophylaxis of cardiovascular disease in a long-term-care facility.

Sleeper RB, Rojas-Fernandez C.

Am J Health Syst Pharm. 2002 Jul 1;59(13):1294-5. No abstract available.

PMID:
12116896
43.

Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy.

Lane LA, Rojas-Fernandez C.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1268-72. Review.

PMID:
12086562
44.

Drug administration through enteral feeding catheters.

Seifert CF, Johnston BA, Rojas-Fernandez C.

Am J Health Syst Pharm. 2002 Feb 15;59(4):378-9. No abstract available.

PMID:
11885404
45.

Celecoxib- and rofecoxib-induced delirium.

Macknight C, Rojas-Fernandez CH.

J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):305-6. No abstract available.

PMID:
11449042
46.

Successful use of donepezil for the treatment of dementia with Lewy bodies.

Rojas-Fernandez CH.

Ann Pharmacother. 2001 Feb;35(2):202-5.

PMID:
11215841
47.

Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?

Rojas-Fernandez CH, Lanctot KL, Allen DD, MacKnight C.

Pharmacotherapy. 2001 Jan;21(1):74-102. Review.

PMID:
11191740
48.

Suboptimal use of antidepressants in the elderly: a population-based study in Nova Scotia.

Rojas-Fernandez C, Thomas VS, Carver D, Tonks R.

Clin Ther. 1999 Nov;21(11):1937-50.

PMID:
10890265
49.

Quetiapine for sexually inappropriate behavior in dementia.

MacKnight C, Rojas-Fernandez C.

J Am Geriatr Soc. 2000 Jun;48(6):707. No abstract available.

PMID:
10855614
50.

Potential interaction between celecoxib and warfarin.

Haase KK, Rojas-Fernandez CH, Lane L, Frank DA.

Ann Pharmacother. 2000 May;34(5):666-7. No abstract available.

PMID:
10852097

Supplemental Content

Loading ...
Support Center